Tratament revoluționar: o singură injecție ar putea reduce colesterolul „rău” pentru un an

An experimental gene therapy, VERVE-102, has shown promise in significantly lowering LDL cholesterol levels with a single dose. The treatment modifies a gene related to cholesterol regulation and has maintained effects for up to a year without serious safety issues reported. Published in The New England Journal of Medicine, the study suggests that this therapy could potentially replace daily cholesterol medications in the future. While statins require ongoing use, VERVE-102 aims for a long-lasting impact with just one administration. Further research is necessary to confirm its efficacy and safety for widespread use.